New mechanisms in the pathogenesis of asthma and other lung diseases

Thematic Poster Session
Chairs: D. Hartl (Tuebingen, Germany), P. Hiemstra (Leiden, Netherlands), M. Mall (Heidelberg, Germany), H. Yuksel (Manisa, Turkey)

Download all media

LSC 2014 abstract - Endotracheal intubation triggers neutrophil extracellular traps D. Scozzi, C. Puyo, D. Peruzzi, K. Toth, S. Mariotta, A. Gelman (Roma, Italy; St. Louis, United States Of America)
Complex extracellular matrix modulates neutrophil migration in vitro M. Weckmann, G. Nissen, T. Becker, E. Ehlers-Jeske, M. Kopp (Lübeck, Germany)
Expression of CX3CL1 and CX3CR1 in human asthmatic lung in relation to cell survival D. Cunoosamy, X. H. Zhou, M. Rehnberg, K. Svensson, K. Sandberg (Mölndal, Sweden)
The expression of the negative regulator of gene transcription SOCS3 as the crucial marker in the asthma pathogenesis V. Mineev, L. Sorokina, M. Nyoma, V. Lim, V. Trofimov (Saint-Petersburg, Russian Federation)
Association between airway inflammation, airway remodelling and physiological changes in asthma R. Berair, S. Gonem, V. Mistry, A. Singapuri, N. Rana, R. Kay, S. Siddiqui, C. Brightling (Leicester, United Kingdom; Basel, Switzerland)
Ration of IL1beta / IL1-receptor antagonist (RA) in alveolar macrophages of induced sputum of patients with asthma during long-term follow-up S. Pospelova, S. Sobchenko, V. Kravtsov (Saint-Petersburg, Russian Federation)
Adult asthma patients reporting exacerbations triggered by upper airway infection have increased total IgE and sensitization to HDM A. Bjerregård, A. Sverrild, V. Backer, C. Porsbjerg (Copenhagen, Denmark)
Mutually exclusive Th2 and Th17 bronchial gene expression signatures are associated with eosinophilia in asthma D. Choy, A. Shikotra, S. Siddiqui, D. Nagarkar, A. Abbas, C. Ohri, E. Doran, C. Butler, B. Hargadon, M. Shelley, L. Wu, L. Heaney, J. Arron, P. Bradding (South San Francisco, United States Of America; Leicester, Belfast, United Kingdom)
Nociceptin orphanin FQ (N/OFQ) – N/OFQ peptide (NOP) receptor system plays a key immunomodulatory role in asthma S. Singh, N. Sullo, M. Matteis, G. Spaziano, K. Urbanek, A. De Angelis, R. De Palma, R. Saunders, L. Woodman, B. D'Agostino, C. Brightling, D. Lambert (Leicester, United Kingdom; Naples, Italy)
Association between body mass index (BMI) and markers of eosinophilic inflammation in asthma R. Berair, V. Mistry, A. Singapuri, S. Gonem, C. Newby, S. Siddiqui, R. Kay, C. Brightling (Leicester, United Kingdom; Basel, Switzerland)
Omalizumab prevents smooth muscle cell growth induced by asthmatic serum M. Roth, J. Zhong, M. Tamm (Basel, Switzerland)
Epidemiological, clinical and morphological features of allergic rhinitis and bronchial asthma in patients of different ages M. Gushchin, T. Barkhina, A. Rasulova, V. Golovanjva, S. Polner, S. Gumenyuk (Moscow, Russian Federation)
Serum periostin in obstructive airways disease: Range, relationships and response to corticosteroid J. Fingleton, J. Travers, D. Bowles, R. Strik, R. Siebers, C. Holweg, J. Matthews, M. Weatherall, R. Beasley (Wellington, Lower Hutt, San Francisco, New Zealand)
The airway microbiota is significantly altered in subjects with eosinophilic asthma A. Sverrild, P. Kiilerich, C. Porsbjerg, A. Bergqvist, J. Erjefält, K. Kristiansen, V. Backer (Copenhagen, Denmark; Lund, Sweden)
The U-BIOPRED severe asthma study: Immunopathological characterisation S. Wilson, J. Ward, A. Sousa, J. Corfield, A. Bansal, P. Sterk, F. Chung, R. Djukanovic, S. E. Dahlen, P. Chanez, D. Shaw, N. Krug, T. Sandström, P. Howarth, U-BIOPRED Consortium (Southampton, Uxbridge, Nottingham, Cambridge, London, United Kingdom; Molondal, Stockholm, Umea, Sweden; Amsterdam, Netherlands; Marseille, France; Hannover, Germany)
Role of IL-33/ST2 axis in systemic inflammation of allergic airway disease L. Vocca, A. Sala, S. Gangemi, C. Di Sano, L. Riccobono, C. Uasuf, G. Anzalone, A. Bonanno, R. P. Gagliardo, M. Profita (Palermo, Milan, Messina, Italy)
Lipoxin (LXA₄) as a novel therapy for idiopathic pulmonary fibrosis K. M. Roach, L. Woodman, C. Feghali-Bostwick, P. Bradding (Leicester, United Kingdom; Pittsburgh, United States Of America)
Proteomic investigation of pulmonary sarcoidosis E. Bargagli, C. Landi, A. Carleo, G. Cillis, R. M. Refini, D. Bennett, M. G. Perari, L. Bini, P. Rottoli (Siena, Italy)
Cytotoxic phenotype of alveolar lymphocytes (AL) in bronchoalveolar lavage fluid (BALF) from non-small cell lung cancer (NSCLC) patients A. Gizycka, J. Chorostowska-Wynimko, C. Rybacki, E. Wedrowska, J. Golinska, P. Kopinski (Warsaw, Bydgoszcz, Poland)
Surfactant changes in patients with lung cancer underwent to resection Y. Yamakova, R. Petkov, M. Bangyozova, A. Jordanova, A. Tsanova, Z. Lalchev, V. Ilieva, V. Stenev (Sofia, Bulgaria)